{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T19:32:55Z","timestamp":1769196775993,"version":"3.49.0"},"reference-count":42,"publisher":"Saudi Heart Association","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T00:00:00Z","timestamp":1559001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Saudi Heart Association"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.jsha.2019.05.005","type":"journal-article","created":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:02:07Z","timestamp":1559347327000},"page":"151-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Real-world use of ticagrelor versus clopidogrel in percutaneous coronary intervention-treated ST-elevation myocardial infarction patients: A single-center registry study"],"prefix":"10.37616","volume":"31","author":[{"given":"Leia","family":"Hee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver J.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph G.","family":"Assad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lokesh D.","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig P.","family":"Juergens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sidney","family":"Lo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian J.","family":"Mussap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"24531","reference":[{"key":"10.1016\/j.jsha.2019.05.005_b0005","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/jama.2009.1232","article-title":"Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy","volume":"302","author":"Shuldiner","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jsha.2019.05.005_b0010","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jsha.2019.05.005_b0015","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jsha.2019.05.005_b0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/ejcts\/ezx334","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","volume":"53","author":"Valgimigli","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jsha.2019.05.005_b0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jamacardio.2018.0612","article-title":"Ticagrelor vs clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: a randomized clinical trial","volume":"3","author":"Berwanger","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jsha.2019.05.005_b0030","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijcard.2016.04.044","article-title":"Comparison of short-term clinical outcomes between ticagrelor versus clopidogrel in patients with acute myocardial infarction undergoing successful revascularization; from Korea Acute Myocardial Infarction Registry\u2014National Institute of Health","volume":"215","author":"Park","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jsha.2019.05.005_b0035","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1136\/heartjnl-2013-305196","article-title":"International differences in acute coronary syndrome patients\u2019 baseline characteristics, clinical management and outcomes in Western Europe: the EURHOBOP study","volume":"100","author":"Andr\u00e9","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.jsha.2019.05.005_b0040","first-page":"2551","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Steg","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jsha.2019.05.005_b0045","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials a consensus report from the bleeding academic research consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.jsha.2019.05.005_b0050","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/heart.86.5.485","article-title":"Angiographic assessment of myocardial perfusion: TIMI myocardial perfusion (TMP) grading system","volume":"86","author":"Appleby","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.jsha.2019.05.005_b0055","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.108.828541","article-title":"Baseline risk of major bleeding in non-ST-segment-elevation myocardial infarction","volume":"119","author":"Subherwal","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jsha.2019.05.005_b0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1062-1458(00)00159-8","article-title":"The TIMI risk score for unstable angina\/non\u2013ST-elevation MI: a method for prognostication and therapeutic decision making","volume":"10","author":"Antman","year":"2001","journal-title":"ACC Curr J Rev"},{"key":"10.1016\/j.jsha.2019.05.005_b0065","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.291.22.2727","article-title":"A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry","volume":"291","author":"Eagle","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jsha.2019.05.005_b0070","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jsha.2019.05.005_b0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d3527","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial","volume":"342","author":"James","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.jsha.2019.05.005_b0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jamacardio.2016.1017","article-title":"Long-term tolerability of ticagrelor for the secondary prevention of major adverse cardiovascular events: a secondary analysis of the PEGASUS-TIMI 54 Trial","volume":"1","author":"Bonaca","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jsha.2019.05.005_b0085","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1253\/circj.CJ-15-0112","article-title":"Ticagrelor vs. clopidogrel in Japanese, Korean and Taiwanese patients with acute coronary syndrome\u2013randomized, double-blind, phase III PHILO study","volume":"79","author":"Goto","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/j.jsha.2019.05.005_b0090","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1093\/eurheartj\/ehw284","article-title":"Outcomes in patients treated with ticagrelor or clopidogrel after acute myocardial infarction: experiences from SWEDEHEART registry","volume":"37","author":"Sahl\u00e9n","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jsha.2019.05.005_b0095","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa0708191","article-title":"Bivalirudin during primary PCI in acute myocardial infarction","volume":"358","author":"Stone","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jsha.2019.05.005_b0100","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jacc.2005.09.060","article-title":"A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes","volume":"47","author":"Rao","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jsha.2019.05.005_b0105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4244\/EIJY14M09_11","article-title":"Association of spontaneous and procedure-related bleeds with short-and long-term mortality after acute coronary syndromes: an analysis from the PLATO trial","volume":"11","author":"Ducrocq","year":"2015","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jsha.2019.05.005_b0110","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jsha.2019.05.005_b0115","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/CIRCULATIONAHA.108.808311","article-title":"Antiplatelet therapy and stent thrombosis after sirolimus-eluting stent implantation","volume":"119","author":"Kimura","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jsha.2019.05.005_b0120","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.113.001437","article-title":"Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents clinical perspective: results in 423 965 patients in the Linked National Cardiovascular Data Registry and Centers for Medicare & Medicaid services payer databases","volume":"127","author":"Kumar","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jsha.2019.05.005_b0125","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jcin.2008.06.011","article-title":"Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent: data from an observational cohort study of drug-eluting versus bare-metal stents","volume":"1","author":"Park","year":"2008","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jsha.2019.05.005_b0130","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/FJC.0000000000000459","article-title":"Efficacy and safety of novel oral P2Y12 receptor inhibitors in patients with ST-segment elevation myocardial infarction undergoing PCI: a systematic review and meta-analysis","volume":"69","author":"Sun","year":"2017","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jsha.2019.05.005_b0135","first-page":"133","article-title":"Trans-radial versus trans-femoral access in patients with end-stage liver disease undergoing cardiac catheterization","volume":"4","author":"Feng","year":"2014","journal-title":"Am J Cardiovasc Dis"},{"key":"10.1016\/j.jsha.2019.05.005_b0140","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1016\/S0140-6736(15)60292-6","article-title":"Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial","volume":"385","author":"Valgimigli","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jsha.2019.05.005_b0145","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jcin.2013.04.010","article-title":"Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials","volume":"6","author":"Karrowni","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jsha.2019.05.005_b0150","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jsha.2019.05.005_b0155","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"Windecker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jsha.2019.05.005_b0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ehjcvp\/pvv034","article-title":"Contemporary use of ticagrelor in patients with acute coronary syndrome: insights from Swedish Web System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)","volume":"2","author":"Sahl\u00e9n","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jsha.2019.05.005_b0165","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.4244\/EIJ-D-17-00634","article-title":"Clopidogrel or ticagrelor in acute coronary syndrome patients treated with newer-generation drug-eluting stents: CHANGE DAPT","volume":"13","author":"Zocca","year":"2017","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jsha.2019.05.005_b0170","first-page":"182","article-title":"Accuracy of bleeding scores for patients presenting with myocardial infarction: a meta-analysis of 9 studies and 13 759 patients","volume":"11","author":"Taha","year":"2015","journal-title":"Post\u0119py Kardiol Interwencyjnej"},{"key":"10.1016\/j.jsha.2019.05.005_b0175","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s11239-016-1366-z","article-title":"Predictive performance of adding platelet reactivity on top of CRUSADE score for 1-year bleeding risk in patients with acute coronary syndrome","volume":"42","author":"Li","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jsha.2019.05.005_b0180","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.ihj.2016.03.007","article-title":"CRUSADE bleeding score as a predictor of bleeding events in patients with acute coronary syndrome in Zagazig University Hospital","volume":"68","author":"Al-Daydamony","year":"2016","journal-title":"Indian Heart J"},{"key":"10.1016\/j.jsha.2019.05.005_b0185","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12872-017-0524-3","article-title":"Ticagrelor versus clopidogrel in real-world patients with ST elevation myocardial infarction: 1-year results by propensity score analysis","volume":"17","author":"Vercellino","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jsha.2019.05.005_b0190","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/imj.13595","article-title":"Contemporary antiplatelet therapy in acute coronary syndromes: are there differences in outcomes and discontinuation between clopidogrel and ticagrelor?","volume":"47","author":"Harding","year":"2017","journal-title":"Intern Med J"},{"key":"10.1016\/j.jsha.2019.05.005_b0195","first-page":"110","article-title":"Ticagrelor in the real world: the midland regional cardiac network experience","volume":"128","author":"Lee","year":"2015","journal-title":"N Z Med J"},{"key":"10.1016\/j.jsha.2019.05.005_b0200","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","article-title":"Prehospital ticagrelor in ST-segment elevation myocardial infarction","volume":"371","author":"Montalescot","year":"2014","journal-title":"New Engl J Med"},{"key":"10.1016\/j.jsha.2019.05.005_b0205","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1093\/eurheartj\/ehx175","article-title":"Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study","volume":"38","author":"Cuisset","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jsha.2019.05.005_b0210","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1093\/eurheartj\/ehu161","article-title":"Prospective validation of the Bleeding Academic Research Consortium classification in the all-comer PRODIGY trial","volume":"35","author":"Vranckx","year":"2014","journal-title":"Eur Heart J"}],"container-title":["Journal of the Saudi Heart Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1016731519301150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1016731519301150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1016731519301150?httpAccept=text\/plain","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T17:46:07Z","timestamp":1666115167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1016731519301150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S1016731519301150"],"URL":"https:\/\/doi.org\/10.1016\/j.jsha.2019.05.005","relation":{},"ISSN":["1016-7315"],"issn-type":[{"value":"1016-7315","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world use of ticagrelor versus clopidogrel in percutaneous coronary intervention-treated ST-elevation myocardial infarction patients: A single-center registry study","name":"articletitle","label":"Article Title"},{"value":"Journal of the Saudi Heart Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsha.2019.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}